HT
Therapeutic Areas
Healios Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HLCM051 (MultiStem) | Acute Respiratory Distress Syndrome (ARDS) | Phase 2/3 |
| iPSC-derived RPE cells | Age-Related Macular Degeneration | Preclinical/Research |
| eNK Cells | Solid Tumors (Mesothelioma, Lung, HCC, Gastric) | Preclinical/Research |